Published in Women's Health Weekly, April 17th, 2006
"Efflux transporters, p-glycoprotein and BCRP, located at barrier sites such as the blood-brain barrier may affect distribution of steroids used for treating chronic inflammatory conditions and thus the extent to which they may perturb the hypothalamic-pituitary-adrenal axis. In the present study, 6 different glucocorticoids were investigated for their possible interactions with these efflux transporters," investigators in England reported.
"Beclomethasone dipropionate, mometasone furoate and ciclesonide active principle but not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.